Mesoblast (MESO) Intangibles (2015 - 2025)
Mesoblast's (MESO) quarterly Intangibles came in at $568.8 million in Q4 2025, down 1.06% year-on-year from $574.9 million in Q4 2024, and down 0.53% quarter-over-quarter from $571.8 million in Q2 2025.
Mesoblast (MESO) Intangibles (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Intangibles across 11 years of filings, most recently posting $568.8 million for Q4 2025.
- Intangibles for Q4 2025 came in at $568.8 million, down 1.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $568.8 million (down 1.06% YoY), and the FY2025 annual result was $571.8 million, down 0.68% from the prior year.
- Intangibles came in at $568.8 million for Q4 2025 at Mesoblast, down from $571.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $580.9 million in Q1 2021 to a low of $568.8 million in Q4 2025.
- The 5-year median for Intangibles is $577.9 million (2022), against an average of $577.2 million.
- Across the five-year window, Intangibles declined 0.17% in 2021 and decreased 1.06% in 2025, its largest moves.
- Mesoblast's Intangibles stood at $579.8 million in 2021, then dropped by 0.33% to $577.9 million in 2022, then retreated by 0.23% to $576.6 million in 2023, then fell by 0.29% to $574.9 million in 2024, then dropped by 1.06% to $568.8 million in 2025.
- The last three Intangibles figures came in at $568.8 million (Q4 2025), $571.8 million (Q2 2025), and $574.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 568.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 568.80 Mn |
| Jun 30, 2025 | 571.83 Mn |
| Dec 31, 2024 | 574.88 Mn |
| Jun 30, 2024 | 575.74 Mn |
| Dec 31, 2023 | 576.56 Mn |
| Jun 30, 2023 | 577.18 Mn |
| Mar 31, 2023 | 577.53 Mn |
| Dec 31, 2022 | 577.90 Mn |
| Sep 30, 2022 | 578.28 Mn |
| Jun 30, 2022 | 578.65 Mn |
| Mar 31, 2022 | 578.95 Mn |
| Dec 31, 2021 | 579.84 Mn |
| Sep 30, 2021 | 580.18 Mn |
| Jun 30, 2021 | 580.55 Mn |
| Mar 31, 2021 | 580.94 Mn |
| Dec 31, 2020 | 581.33 Mn |
| Sep 30, 2020 | 581.22 Mn |
| Jun 30, 2020 | 581.60 Mn |
| Mar 31, 2020 | 581.94 Mn |
| Dec 31, 2019 | 582.34 Mn |